Skip to content

Outcomes of single dose peri-procedural antibiotic prophylaxis for endoscopic ultrasound guided fine needle aspiration of pancreatic cystic lesions.

Rates of infection in patients with pancreatic cyst endoscopic ultrasound fine needle aspiration given antibiotic prophylaxis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12613001305718
Enrollment
100
Registered
2013-11-22
Start date
2011-02-04
Completion date
2016-01-10
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Endoscopic ultrasound can obtain fluid using a technique known as fine needle aspiration (FNA). This involves a needle entering a pancreatic cyst and sucking fluid out. However, this test risks introducing gut bacteria into a normally sterile space. As such antibiotics may be effective to prevent infections. We aim to test whether Tazocin or Ciprofloxacin if penicillin allergy is present, prevents infections or is associated with increased harm.

Interventions

Patients having endoscopic ultrasound fine needle aspiration are at risk of iatrogenic infections due to the procedure. Currently there are no firm guidelines as to whether antibiotics are required or if they are, what antibiotics should be used. There have been no studies focusing on Tazocin (tazobactam, piperacillin) at the time of endoscopic ultrasound fine needle aspiration (EUS FNA). We will include all cases of EUS FNA requiring antibiotic prophylaxis and follow up patients following disch

Patients having endoscopic ultrasound fine needle aspiration are at risk of iatrogenic infections due to the procedure. Currently there are no firm guidelines as to whether antibiotics are required or if they are, what antibiotics should be used. There have been no studies focusing on Tazocin (tazobactam, piperacillin) at the time of endoscopic ultrasound fine needle aspiration (EUS FNA). We will include all cases of EUS FNA requiring antibiotic prophylaxis and follow up patients following discharge home to determine whether they develop acute or chronic infections. Observational study will be conducted determining the rates of sepsis following EUS FNA (single periprocedural dose IV tazocin or ciprofloxacin) on telephone follow up 1 year post-procedure

Sponsors

Concord Hospital
Lead SponsorHospital

Eligibility

Sex/Gender
All
Age
16 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

Age 16 - 90 Pancreatic cyst requiring fine needle aspiration Consenting to procedure

Exclusion criteria

Coagulopathy Not possible to safely perform EUS FNA eg cyst not well-positioned

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026